CONMED Corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. Our products are technological leaders in the specialties that we serve: Orthopaedics, General Surgery, Gynecology, Gastroenterology, Pulmonology, and Anesthesiology. CONMED's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. Our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. We strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. CONMED is headquartered in beautiful, upstate New York (Utica), and employs approximately 3500 people worldwide. Our employees are located in 8 manufacturing, distribution or design facilities in the United States and in sales offices throughout the world. Our domestic locations include: Utica, NY, Largo, FL, Anaheim CA, San Mateo, CA, Westborough, MA, Edison, NJ, Centennial, CO, and Atlanta, GA. Our international facilities and presence spans more than 20 locations throughout Europe, Australia, Latin America, Asia, North America and the Middle East.

Utica, US
Size (employees)
3,300 (est)-2%
Conmed was founded in 1970 and is headquartered in Utica, US

Conmed Office Locations

Conmed has offices in Utica, Hartford, Westborough, Phoenix and in 55 other locations
Utica, US (HQ)
525 French Rd

Conmed Metrics

Conmed Financial Metrics

Revenue (2016)

$763.5 m

Revenue growth (2015-16), %


Gross profit

$408.3 m

Gross profit margin (2016), %


Net income (2016)

$14.7 m

Market capitalization (21-Mar-2017)

$1.2 b

Closing share price (21-Mar-2017)


Cash (31-Dec-2016)

$27.4 m
Conmed's current market capitalization is $1.2 b.
Conmed's revenue was reported to be $763.5 m in FY, 2016 which is a 6.2% increase from the previous period.
FY, 2013FY, 2014FY, 2015FY, 2016


$762.7 m$740.1 m$719.2 m$763.5 m

Revenue growth, %


Cost of goods sold

$350.3 m$336 m$337.5 m$355.2 m

Gross profit

$412.4 m$404.1 m$381.7 m$408.3 m

Gross profit Margin, %


Operating expense total

$355.9 m$351.3 m$330.5 m$370.7 m


$56.5 m$52.8 m$51.2 m$37.7 m

EBIT margin, %


Interest expense

$5.6 m$6.1 m$6 m$15.4 m

Pre tax profit

$50.6 m$46.7 m$45.1 m$19.4 m

Income tax expense

$14.7 m$14.5 m$14.6 m$4.7 m

Net Income

$35.9 m$32.2 m$30.5 m$14.7 m
FY, 2013FY, 2014FY, 2015FY, 2016


$54.4 m$66.3 m$72.5 m$27.4 m

Accounts Receivable


$143.2 m$148.1 m$166.9 m$135.9 m

Current Assets

$372.1 m$381.2 m$407.5 m$330.5 m


$139 m$133.4 m$125.5 m$122 m


$248.4 m$256.2 m$260.7 m$397.7 m

Total Assets

$1.1 b$1.1 b$1.1 b$1.3 b

Accounts Payable

$27.4 m$23.8 m$34.7 m$41.6 m

Total Debt

$215.6 m$241.4 m$270.8 m$498.5 m

Current Liabilities

$111.3 m$116 m$119.7 m$114 m

Additional Paid-in Capital

$326.4 m$319.8 m$324.9 m$329.3 m

Retained Earnings

$395.9 m$406.1 m$414.5 m$406.9 m

Total Equity

$606.3 m$581.3 m$585.1 m$580.6 m

Debt to Equity Ratio

0.4 x0.4 x0.5 x0.9 x

Debt to Assets Ratio

0.2 x0.2 x0.2 x0.4 x

Financial Leverage

1.8 x1.9 x1.9 x2.3 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

$35.9 m$32.2 m$30.5 m$14.7 m

Depreciation and Amortization

$18.7 m$19.8 m$18.7 m$20.5 m

Accounts Receivable

($798 k)$5.3 m($9.6 m)($6.4 m)


($1.8 m)($21 m)($35 m)$3.1 m

Accounts Payable

$4.2 m($3.4 m)$11.5 m$2.1 m

Cash From Operating Activities

$80.9 m$65.2 m$48.1 m$38.2 m

Purchases of PP&E

($18.4 m)($15.4 m)($15 m)($14.8 m)

Cash From Investing Activities

($18.4 m)($20.7 m)($24.4 m)($266 m)

Interest Paid

$5.1 m$5.5 m$5.4 m$13.8 m

Income Taxes Paid

($1.1 m)$5.3 m($1.4 m)($200 k)

Conmed Market Value History

Conmed Job Categories

Conmed Median Salaries

Source: 22 public H-1B filings from Conmed

Conmed Company Life

You may also be interested in